{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:18:05Z","timestamp":1774070285498,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10815-012-9812-0","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T12:28:12Z","timestamp":1340368092000},"page":"877-882","source":"Crossref","is-referenced-by-count":9,"title":["Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF\/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35\u00a0years of age?"],"prefix":"10.1007","volume":"29","author":[{"given":"Carla","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Stadtmauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Oehninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,23]]},"reference":[{"key":"9812_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fertnstert.2004.03.020","volume":"82","author":"B Acevedo","year":"2004","unstructured":"Acevedo B, Sanchez M, Gomez JL, Cuadros J, Ricciarelli E, Hernandez ER. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril. 2004;82:343\u20137.","journal-title":"Fertil Steril"},{"key":"9812_CR2","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;CD001750.","DOI":"10.1002\/14651858.CD001750.pub3"},{"key":"9812_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","volume":"84","author":"M Arslan","year":"2005","unstructured":"Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005;84:555\u201369.","journal-title":"Fertil Steril"},{"key":"9812_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1016601110424","volume":"18","author":"G Barroso","year":"2001","unstructured":"Barroso G, Oehninger S, Monzo A, Kolm P, Gibbons WE, Muasher SJ. High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet. 2001;18:499\u2013505.","journal-title":"J Assist Reprod Genet"},{"key":"9812_CR5","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/humrep\/dei101","volume":"20","author":"S Bjercke","year":"2005","unstructured":"Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T. IVF\/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod. 2005;20:2441\u20137.","journal-title":"Hum Reprod"},{"key":"9812_CR6","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/humrep\/der228","volume":"26","author":"QF Cai","year":"2011","unstructured":"Cai QF, Wan F, Huang R, Zhang HW. Factors predicting the cumulative outcome of IVF\/ICSI treatment: a multivariable analysis of 2450 patients. Hum Reprod. 2011;26:2532\u201340.","journal-title":"Hum Reprod"},{"key":"9812_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/del340","volume":"22","author":"I Cedrin-Durnerin","year":"2007","unstructured":"Cedrin-Durnerin I, Bstandig B, Parneix I, Bied-Damon V, Avril C, Decanter C, Hugues JN. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22:109\u201316.","journal-title":"Hum Reprod"},{"key":"9812_CR8","unstructured":"Centers for Disease Control and Prevention. 2009 Assisted Reproductive Technology and Success Rates. National Summary and Fertility Clinic Reports 2007."},{"key":"9812_CR9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/humrep\/den468","volume":"24","author":"P Devroey","year":"2009","unstructured":"Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomas C, Fauser BC. Improving the patient\u2019s experience of IVF\/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2009;24:764\u201374.","journal-title":"Hum Reprod"},{"key":"9812_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10815-006-9085-6","volume":"24","author":"D Dowling-Lacey","year":"2007","unstructured":"Dowling-Lacey D, Jones E, Mayer J, Bocca S, Stadtmauer L, Oehninger S. Elective transfer of two embryos: reduction of multiple gestations while maintaining high pregnancy rates. J Assist Reprod Genet. 2007;24:11\u20135.","journal-title":"J Assist Reprod Genet"},{"key":"9812_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(16)53282-8","volume":"53","author":"Y Gonen","year":"1990","unstructured":"Gonen Y, Jacobson W, Casper RF. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril. 1990;53:282\u20137.","journal-title":"Fertil Steril"},{"key":"9812_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.rbmo.2011.06.016","volume":"23","author":"G Griesinger","year":"2011","unstructured":"Griesinger G, Shapiro DB, Kolibianakis EM, Witjes H, Mannaerts BM. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reprod Biomed Online. 2011;23:457\u201365.","journal-title":"Reprod Biomed Online"},{"key":"9812_CR13","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","volume":"22","author":"JA Huirne","year":"2007","unstructured":"Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod. 2007;22:2805\u201313.","journal-title":"Hum Reprod"},{"key":"9812_CR14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","volume":"92","author":"CH Kim","year":"2009","unstructured":"Kim CH, Jeon GH, Cheon YP, Jeon I, Kim SH, Chae HD, Kang BM. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection. Fertil Steril. 2009;92:1758\u201360.","journal-title":"Fertil Steril"},{"key":"9812_CR15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1210\/jc.81.3.1038","volume":"81","author":"NA Klein","year":"1996","unstructured":"Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996;81:1038\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"9812_CR16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/dei348","volume":"21","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod. 2006;21:352\u20137.","journal-title":"Hum Reprod"},{"key":"9812_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2010.05.052","volume":"95","author":"EM Kolibianakis","year":"2011","unstructured":"Kolibianakis EM, Venetis CA, Kalogeropoulou L, Papanikolaou E, Tarlatzis BC. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertil Steril. 2011;95:558\u201362.","journal-title":"Fertil Steril"},{"key":"9812_CR18","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/humrep\/deh471","volume":"19","author":"EM Kolibianakis","year":"2004","unstructured":"Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod. 2004;19:2490\u20136.","journal-title":"Hum Reprod"},{"key":"9812_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.fertnstert.2006.07.1457","volume":"87","author":"NG Mahutte","year":"2007","unstructured":"Mahutte NG, Arici A. Role of gonadotropin-releasing hormone antagonists in poor responders. Fertil Steril. 2007;87:241\u20139.","journal-title":"Fertil Steril"},{"key":"9812_CR20","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.fertnstert.2010.02.001","volume":"93","author":"DR Meldrum","year":"2010","unstructured":"Meldrum DR, Schoolcraft W. Microdose flare versus antagonist for poor responders. Fertil Steril. 2010;93:e35. author reply e36.","journal-title":"Fertil Steril"},{"key":"9812_CR21","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.fertnstert.2008.01.007","volume":"91","author":"DR Meldrum","year":"2009","unstructured":"Meldrum DR, Scott Jr RT, Levy MJ, Alper MM, Noyes N. Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss. Fertil Steril. 2009;91:1963\u20135.","journal-title":"Fertil Steril"},{"key":"9812_CR22","doi-asserted-by":"crossref","unstructured":"Mochtar MH, Van der V, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007;CD005070.","DOI":"10.1002\/14651858.CD005070.pub2"},{"key":"9812_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jech.43.3.275","volume":"43","author":"MF Murphy","year":"1989","unstructured":"Murphy MF, Campbell MJ, Bone M. Is there an increased risk of twinning after discontinuation of the oral contraceptive pill? J Epidemiol Commun Health. 1989;43:275\u20139.","journal-title":"J Epidemiol Commun. Health"},{"key":"9812_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2010.04.016","volume":"67","author":"G Neal-Perry","year":"2010","unstructured":"Neal-Perry G, Nejat E, Dicken C. The neuroendocrine physiology of female reproductive aging: An update. Maturitas. 2010;67:34\u20138.","journal-title":"Maturitas"},{"key":"9812_CR25","first-page":"137","volume":"63","author":"S Oehninger","year":"2011","unstructured":"Oehninger S. Ovulation induction in IVF. Minerva Ginecol. 2011;63:137\u201356.","journal-title":"Minerva Ginecol"},{"key":"9812_CR26","doi-asserted-by":"crossref","unstructured":"Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for \u2018poor responders\u2019 to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev. 2010;CD004379.","DOI":"10.1002\/14651858.CD004379.pub3"},{"key":"9812_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","volume":"21","author":"L Rombauts","year":"2006","unstructured":"Rombauts L, Healy D, Norman RJ. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod. 2006;21:95\u2013103.","journal-title":"Hum Reprod"},{"key":"9812_CR28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","volume":"51","author":"RT Scott","year":"1989","unstructured":"Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651\u20134.","journal-title":"Fertil Steril"},{"key":"9812_CR29","doi-asserted-by":"crossref","unstructured":"Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer JA. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2010;CD006109.","DOI":"10.1002\/14651858.CD006109.pub2"},{"issue":"5","key":"9812_CR30","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1210\/jc.83.5.1507","volume":"83","author":"The European Recombinant Human LH Study Group","year":"1998","unstructured":"The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab. 1998;83(5):1507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"9812_CR31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(99)00025-6","volume":"59","author":"AM Heusden van","year":"1999","unstructured":"van Heusden AM, Fauser BC. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception. 1999;59:237\u201343.","journal-title":"Contraception"},{"key":"9812_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1749-6632.1985.tb37540.x","volume":"442","author":"LL Veeck","year":"1985","unstructured":"Veeck LL. Extracorporeal maturation: Norfolk, 1984. Ann N Y Acad Sci. 1985;442:357\u201367.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-012-9812-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-012-9812-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-012-9812-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T01:54:15Z","timestamp":1561859655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-012-9812-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,23]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9812"],"URL":"https:\/\/doi.org\/10.1007\/s10815-012-9812-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,23]]}}}